Fri Jan 10 03:39:23 UTC 2025: ## Standard Glass Lining IPO Oversubscribed, Allotment Announced; Strong Listing Expected

**Mumbai, January [Date of Publication]** – The Standard Glass Lining IPO, which concluded on January 8th, has been massively oversubscribed, receiving a staggering 185.48 times the number of applications. The allotment process is complete, with investors already receiving bank debit messages confirming their allocation. Investors can also verify their allotment status online through the BSE, NSE, and Kfin Technologies websites.

The IPO, priced between ₹133 and ₹140 per share, raised ₹410.05 crore through a combination of fresh issuance and an offer for sale (OFS). The retail portion was oversubscribed 65.71 times, while non-institutional investors (NII) and qualified institutional buyers (QIB) showed even stronger interest, with subscriptions of 275.21 and 327.76 times, respectively.

The grey market premium (GMP) currently stands at ₹78, representing a 55.71% premium over the issue price. This suggests strong investor confidence and anticipates a significant listing gain when shares begin trading on the BSE and NSE on Monday, January 13th.

Standard Glass Lining Ltd. provides comprehensive solutions for pharmaceutical and chemical manufacturers, including design, engineering, and installation. The company’s client list includes prominent names like Aurobindo Pharma, Cadila Pharmaceuticals, and Granules India. Proceeds from the fresh issue will be utilized for debt repayment, investment in a subsidiary, strategic acquisitions, and general corporate purposes.

IIFL Capital Services and Motilal Oswal Investment Advisors acted as book-running lead managers for the IPO, while KFin Technologies served as the registrar. Investors can check their allotment status by visiting the BSE website ([link to BSE website]), the NSE website, or the Kfin Technologies portal ([link to Kfin Technologies portal]).

Read More